Bruker Corporation filings document financial results, capital returns, governance actions and proxy matters for a scientific instruments and diagnostics company.
Recent Form 8-K disclosures cover quarterly and annual operating results, outlook commentary, segment information for Bruker Scientific Instruments and Bruker Energy & Supercon Technologies, and dividends on common stock and 6.375% Mandatory Convertible Preferred Stock, Series A. The definitive proxy statement covers board elections, executive compensation, pay-versus-performance data, shareholder voting items and governance practices. Other material-event filings record board composition changes and executive transition arrangements.
FRANCIS LAURA reported acquisition or exercise transactions in this Form 4 filing.
Bruker Corporation director Laura Francis received an equity award of 4,520 shares of Common Stock in the form of restricted stock units on February 15, 2026. The RSUs will vest in a single installment on February 15, 2027. After this grant, she holds 9,018 shares directly.
Bruker Corp director Jack Phillips reported an equity award. On February 15, 2026, he acquired 4,520 shares of Common Stock through a grant classified as a “grant, award, or other acquisition.” The footnote explains this is represented by Restricted Stock Units that will vest in a single installment on February 15, 2027, when each unit will convert into one share of Common Stock. Following this award, his directly held position is reported as 4,520 shares.
BRUKER CORP director John A. Ornell received an equity grant of 4,520 shares of Common Stock in the form of restricted stock units. The award was reported at no cash purchase price and increased his directly held stake to 39,732 shares after the transaction.
The RSUs will vest in a single installment on February 15, 2027. On that vesting date, each restricted stock unit will automatically convert into one share of Bruker common stock, aligning the director’s compensation with future company performance over the vesting period.
BRUKER CORP director William A. Linton received an equity award of 4,520 restricted stock units (RSUs). The RSUs were granted at no cash cost and relate to the company’s common stock. After this grant, he directly holds 63,243 shares of common stock.
The footnote explains that these RSUs will vest in a single installment on February 15, 2027, and each RSU will automatically convert into one share of Bruker common stock at that time, aligning the director’s compensation more closely with future shareholder value.
BRUKER CORP director Richard A. Packer received an equity award covering 4,520 shares of common stock as a grant of Restricted Stock Units. The RSUs will vest in a single installment on February 15, 2027, at which time each unit will convert into one share of common stock. After this award, Packer’s directly held common stock, including this grant, is reported at 93,694 shares. The grant was recorded at a price of $0.00 per share, consistent with a stock-based compensation award rather than an open-market purchase.
Bruker Corp director Adelene Q. Perkins received an equity award of 4,520 restricted stock units (RSUs) of Common Stock on February 15, 2026. The RSUs will vest in a single installment on February 15, 2027, and each unit will convert into one share of Common Stock at vesting. After this grant, Perkins beneficially owns 29,144 shares of Common Stock directly.
BRUKER CORP director Cynthia M. Friend reported an equity award of 4,520 units tied to Common Stock. The award is structured as Restricted Stock Units (RSUs) that were granted at no cash cost on the transaction date. All 4,520 RSUs will vest in a single installment on February 15, 2027, and each RSU will automatically convert into one share of Common Stock at that time. Following this grant, she now directly holds 22,536 shares of Common Stock, reflecting her updated ownership position.
BRUKER CORP director Bob Rosenthal reported an equity award. He acquired 4,520 shares of Common Stock through a grant classified as a grant, award, or other acquisition at a stated price of $0.00 per share.
According to the footnote, this grant is in the form of Restricted Stock Units that will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into one share of Common Stock. After this award, Rosenthal directly holds 38,781 shares of Common Stock.
BRUKER CORP Chief Accounting Officer Thomas Bures reported a tax-related share disposition. On the reported date, 274 shares of common stock were withheld at a price of $36.51 per share to satisfy tax withholding obligations tied to previously granted restricted stock units that vested. After this withholding transaction, Bures directly owned 3,198 shares of Bruker common stock, reflecting a routine, non-open-market adjustment for taxes rather than an elective share sale.
Bruker Corp director Hermann Fritz Requardt received an equity grant of 4,520 shares of Common Stock in the form of restricted stock units. The award was granted at a price of $0.00 per share on February 15, 2026 as compensation rather than an open-market purchase.
The RSUs will vest in one installment on February 15, 2027, at which time each unit will automatically convert into one share of Bruker Common Stock. Following this grant, Requardt holds 30,965 shares of Common Stock in direct ownership, aligning his interests more closely with shareholders.